Skip to content
lifestyle.socialsinsider.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
AlzeCure Pharma
AlzeCure Pharma Carries Out a Fully Secured Rights Issue of Approximately SEK 30.1 million
April 26, 2026
AlzeCure Publishes its Year-End Report for January – December 2025
February 26, 2026
Pain Project ACD440 Granted Orphan Drug Status in the EU
February 24, 2026
AlzeCure Pharma Selected to Present at the Bio-Neuroscience conference in Amsterdam
February 10, 2026
←
Previous Page
1
2
3